echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Eur Heart J: Effect of Canagliflozin on Serum Potassium in Patients with Diabetes and Chronic Kidney Disease

    Eur Heart J: Effect of Canagliflozin on Serum Potassium in Patients with Diabetes and Chronic Kidney Disease

    • Last Update: 2021-09-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Hyperkalemia is type 2 diabetes mellitus (T2DM) is a common complication, limits the best blocking renin - vascular angiotensin - aldosterone system agents, particularly in chronic kidney disease (CKD) patients


    Diabetic blood vessels



    Canagliflozin similarly reduced the incidence of laboratory-confirmed hyperkalemia (HR of 0.



    Original source:

    Brendon L Neuen.


    Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.